Trieu Vuong - Nov 22, 2024 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Nov 22, 2024
Transactions value $
$8,627
Form type
4
Date filed
11/26/2024, 11:33 AM
Previous filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $8.63K +298K +0.32% $0.03 92.8M Nov 22, 2024 Direct
holding OTLC Common Stock 16.8M Nov 22, 2024 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Nov 22, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On November 22, 2024, Dr. Trieu purchased 500,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0289.